Anti-Marijuana Groups And Pharma Company Ask Court To Revive Lawsuit Challenging Medicare Hemp Coverage Program
A coalition of anti-marijuana groups and a cannabis-focused biopharmaceutical corporation are asking a federal appeals court to overturn a judge’s dismissal of their lawsuit challenging a new Trump administration initiative to cover up to $500 worth of hemp-derived products each year for eligible Medicare patients. Last month, Judge Trevor N. McFadden dismissed the challenge to […]
Hemp Companies Sue DEA, Challenging Agency’s Claim That Synthetic Cannabis Compound HHC Is Federally Banned
Hemp companies have filed lawsuits challenging the Drug Enforcement Administration’s (DEA) determination that a cannabinoid produced synthetically from components of the cannabis plant is federally illegal. DEA issued a rule last month saying that while it had already considered hexahydrocannabinol (HHC) to be a Schedule I illegal substance under the federal Controlled Substances Act (CSA), […]
Federal Judge Dismisses Anti-Marijuana Groups’ Lawsuit Challenging Medicare Hemp Coverage Program
A federal judge has granted the government’s motion to dismiss marijuana legalization opponents’ lawsuit challenging a new Trump administration initiative to cover up to $500 worth of hemp-derived products each year for eligible Medicare patients. The program being implemented by the Centers for Medicare & Medicaid Services (CMS) focuses largely on CBD but also allows a certain […]